Istari Oncology Announces FDA Granted Fast Track Designation to PVSRIPO for the Treatment of Advanced Melanoma Read more
Aucta Pharma and Oakrum Pharma Announce Launch of Generic Version of JADENU(R) Sprinkle (Deferasirox Granules) Read more
Moderna Submits Authorization Application for its COVID-19 Vaccine in Adolescents in Switzerland Read more
GSK and iTeos Therapeutics announce development and commercialisation collaboration for EOS-448, an anti-TIGIT monoclonal antibody, enabling novel next-generation immuno-oncology combinations Read more
Humanigen Initiates Submission for Lenzilumab Marketing Authorization in COVID-19, to the United Kingdom’s MHRA Read more
HiFiBiO Therapeutics Closes $75 Million Series D Financing to Accelerate Pipeline With Two Lead Immuno-Oncology Programs and Validate Its DIS Approach in the Clinic Read more
Moderna and Tabuk Pharmaceuticals Partner to Commercialize Moderna’s COVID-19 Vaccine in Saudi Arabia Read more
Bristol Myers Squibb and Acceleron Present First Results from Phase 2 BEYOND Study of Reblozyl (luspatercept-aamt) in Adults with Non-Transfusion Dependent(NTD)Beta Thalassemia Read more